Avantor Posts 13% Revenue Drop, 20% Q1 Earnings Cut
Annual revenue has fallen 13% over four years and net margins have shrunk from 12% to 9%. Analysts cut current-quarter earnings estimates by 20% and full-year forecasts by 9%, driving a Zacks Rank #5 Strong Sell.
1. Four-Year Revenue Decline and Margin Compression
Avantor’s annual revenue has fallen roughly 13% over the past four years, while net margins have tightened from about 12% to 9% due to weakening demand and cost pressures in its core laboratory supplies and specialty chemicals segments.
2. Significant Earnings Estimate Reductions
Analysts have trimmed current-quarter earnings estimates by approximately 20% and full-year profit forecasts by about 9%, reflecting ongoing operational challenges and slower-than-expected recovery in key end markets.
3. Weak Sales Forecast and Sell Rating
Consensus projects a further 0.7% sales decline this year followed by a modest 2.4% rebound next year, supporting the stock’s placement at Zacks Rank #5 Strong Sell given persistent structural headwinds.